When does GMP actually start?
Published on: 29/06/2026
GMP does not begin at a single identifiable moment. It begins as soon as controlled processes and regulated decision-making become necessary to ensure product quality and patient safety.
GMP
Evidence & Data Integrity GLP/GCP/GMP expectations by phase
Published on: 18/06/2026
Evidence and data integrity expectations evolve progressively across GLP, GCP, and GMP environments, reflecting the increasing regulatory and patient impact of the data being generated.
Quality CultureGMP
Preparing Quality Systems for Greater Regulatory Transparency in GMP Oversight
Published on: 13/06/2026
Regulatory transparency in Good Manufacturing Practice (GMP) oversight is entering a period of structural change, driven by increasing expectations from regulators, industry stakeholders, and the broader healthcare ecosystem.
GMP
Public Consultation on Greater Transparency for GMP Inspection Outcomes
Published on: 08/06/2026
The Therapeutic Goods Administration (TGA) has commenced a public consultation on a proposal to increase transparency regarding Good Manufacturing Practice (GMP) inspection outcomes for manufacturers of pharmaceutical products supplied to Australia.
GMP